Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 529.05
-18.05 (-3.30%)
Mar 30, 2026, 2:30 PM IST
Krsnaa Diagnostics Market Cap
Krsnaa Diagnostics has a market cap or net worth of 17.75 billion as of March 27, 2026. Its market cap has decreased by -27.20% in one year.
Market Cap
17.75B
Enterprise Value
19.31B
Revenue
7.66B
Ranking
n/a
PE Ratio
22.37
Stock Price
529.05
Market Cap Chart
Since August 16, 2021, Krsnaa Diagnostics's market cap has decreased from 30.99B to 17.75B, a decrease of -42.73%. That is a compound annual growth rate of -11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 17.75B | -24.16% |
| Dec 31, 2025 | 23.40B | -18.16% |
| Dec 31, 2024 | 28.59B | 25.42% |
| Dec 29, 2023 | 22.80B | 57.53% |
| Dec 30, 2022 | 14.47B | -37.50% |
| Dec 31, 2021 | 23.15B | -25.28% |
| Aug 16, 2021 | 30.99B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.59T |
| Apollo Hospitals Enterprise | 1.09T |
| Cipla | 1.00T |
| Medi Assist Healthcare Services | 22.64B |
| Dishman Carbogen Amcis | 22.37B |
| Solara Active Pharma Sciences | 21.33B |
| Panacea Biotec | 19.59B |